NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
We're the depression specialists
Our mission is your remission from depression
Learn more about our treatment options
NeuroStar TMS Therapy
FDA-cleared, non-medication treatment for depression
Not sure where to start?
Learn about the patient journey and our treatment options
Non-drug and FDA-cleared
Non-invasive with no drug-related side effects.
Covered by most insurance
We handle the paperwork.
Fits into your existing treatment
Can be stand-alone treatment or along with your existing medication.
Zero downtime
Drive yourself to and from treatments. Get back to your day right away, including work or school.
Covered by most insurance plans including Medicare and Medicaid at various locations.
Our team works directly with insurance companies to get coverage, file and process claims, and help with appeals when needed.
“I firmly believe that I felt relief from my overbearing, all consuming depression after my very first twenty-minute session. I have felt as if a grey cloud or blanket has been lifted from my life.”
On depression medication since college
"I basically did a 180 on my life. Everything’s changed. The way I look at things and how I act and spend my energy on other things and not on just trying to keep myself alive. It's indescribable."
Tried 9 antidepressants
TMS is fundamentally different from medications and talk therapy, operating through a unique mechanism of action. While medications affect the entire body as they cross the blood-brain barrier, TMS specifically targets the brain areas associated with depression and mood regulation. Because TMS is not a medication, you won’t experience common drug-related side effects like gastrointestinal problems, trouble sleeping, or weight gain.
SPRAVATO® is an FDA-approved esketamine nasal spray, a refined form of ketamine, used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions. It is also covered by most major insurances.
Unlike SPRAVATO®, ketamine is not FDA-approved or covered by many insurances.
NeuroStar TMS therapy fits into your existing treatment. It can be stand-alone treatment or along with your existing medication.
SPRAVATO® treatment can be administered as stand-alone therapy or in combination with other oral antidepressant medications.
NeuroStar TMS therapy and SPRAVATO® are options for patients struggling with depression. Many of our patients have previously tried treatments like talk therapy or antidepressant medication without finding relief, or experiencing difficult-to-manage side effects. There’s no "typical" patient—if you’re suffering or suspect you might have depression, it’s crucial to seek care. We’re here to help, and there’s a good chance we can provide the support you need. Call us to discuss if NeuroStar TMS or SPRAVATO® treatments are right for you. If you are experiencing suicidal thoughts or ideations and need help right away, call or text 988 or go to your nearest emergency room.
We have convenient locations close to home, work, or school, so that you're able to fit our treatments into your schedule
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.